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N-ECCO (Nurses-European Crohn's & Colitis Organisation)
has been an active member of ECCO since 2007, with the
purpose of providing nurse education and the opportunity
for nurses to network internationally. N-ECCO aims through
its activity to improve nurses' knowledge of Inflammatory
Bowel Disease (IBD), share best practice and thus improve
the quality of care accessed across Europe by patients with
IBD.
It has long been acknowledged in N-ECCO that nurses
across Europe perform and provide varying roles in caring for235 4155 and Fax: +44208
hs.net (M. O'Connor).
iting of this document.















ppatients with IBD, given the country-specific variances in
role, title, salary and level of training.
1.1. Aims
The intentions of the N-ECCO Consensus statements are to
identify the positioning of nurses (adult and paediatric) in
ight expect, irrespective of the level of nurse training,
itle or country. The ‘ideal’ standard of nursing care was
eemed an accurate measure and appropriate by the group
order to provide a standard for all nurses working with
eople with IBD.
.2. Methods
he N-ECCO Committee agreed the need for the consensus
tatements on the nurses' role in June 2011. Following the
tandard Operating Procedure (SOP) of ECCO (www.ecco-
d.eu/) a proposal for guidelines, along with draft contents
or the statements, was submitted to the Governing Board.
his was approved in November 2011, with a recommenda-
ion to conduct a survey to gain a clear understanding of the
urrent situation of nurses within Europe in caring for
atients with IBD. The survey was developed and refinedanisation. Published by Elsevier B.V. All rights reserved.
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2012, when all attending nurse delegates were asked to
complete it. Results of this survey will be published
separately.
There was an official call from the ECCO Office for
nursing participants to be involved in the N-ECCO Consensus
in March 2012. Fifteen nurses were selected by the N-ECCO
Committee, following self-nomination, given that they all
had adequate experience of nursing in the field of IBD. In
April 2012, nurses were allocated into one of four working
groups to reflect adequate country variances, with each
group chaired by a N-ECCO Committee member. Between
April & June 2012, each Consensus group was given a
defined section of work, based on the draft content at that
time:
(1) Fundamental IBD Nursing
(2) Advanced IBD Nursing
(3) Nursing care for particular situations (e.g. fatigue,
pregnancy, incontinence)
(4) The Benefit of an IBD Nurse.
Each group performed an electronic literature search using
PubMed (1996–2010), MEDLINE (1966–2010) and EMBASE
(1980–2010), via the OVID platform. The search was conduct-
ed from the inception of the databases to November 2012. The
literature review deployed the recommended grades and
levels of evidence according to the Oxford Centre for Evidence
Based Medicine1 as per the ECCO SOP. Nursing studies tend to
be qualitative, focusing on exploring patient's issues and
experiences, so it is important to acknowledge that the Oxford
system of grading evidence gives greater weight to empiri-
cal evidence and does not rate qualitative research highly.
Although there are grading systems specific to qualitative
research, these do not form part of ECCO's SOP and were
therefore avoided.
In June 2012, a one day meeting took place with all con-
sensus group members present to discuss the evidence and to
draft preliminary statements based on the literature. Be-
tween June & September 2012, each group finalised their
statements and supporting text. This was in turn reviewed at
the N-ECCO Committee Meeting in October 2012. A further
one day meeting took place in November 2012 to vote on
each individual N-ECCO Consensus statement. Each of the 26
Consensus statements were voted upon and, in line with
the ECCO SOP, agreed by greater than 80% of the groups'
vote. Further to this meeting an editorial board consisting
of four group members (M. O'Connor, P. Bager, J. Duncan,
J. Gaarenstroom, L. Younge) refined the supporting text for the
corresponding author and each of the Consensus statements.
1.3. Format
The Consensus statements have been divided into three
sections:
(1) Fundamental Inflammatory Bowel Disease Nursing
(2) Advanced Inflammatory Bowel Disease Nursing
(3) The Perspectives of IBD Nursing.
Fundamental IBD Nursing identifies the basic nursing care
required to address the needs of patients with IBD. TheConsensus group suggests that these needs can be addressed
by nurses working in various settings. The statements within
this section also pertain to those working at an advanced
level, as the Consensus group acknowledged that fundamen-
tal nursing care & skills were developed and refined with
experience in advanced nursing practice.
The section on Advanced IBD Nursing refers to those
nurses who, with experience, training and/or education,
are practicing advanced nursing care. The statements
within this section aim to identify the role of the advanced
nurse, acknowledging the expertise in care and manage-
ment of caseloads of patients with IBD, whilst also
recognising the limitations relevant to this level of nursing
care.
The section on the Perspectives of IBD Nursing acknowl-
edges the value of IBD nurses and identifies that there is
scarce evidence available within literature to support the
value of IBD nurses in improving patient outcomes.
2. Fundamental Inflammatory Bowel Disease
(IBD) Nursing
2.1. Definition and requirements
N-ECCO Statement 2A
Nurses in contactwith patientswith IBDworking in any
setting, need to have basic knowledge of the diseases,
know the difference between Crohn's disease and
ulcerative colitis, and appreciate the importance of
establishing timely therapeutic interventions. Aware-
ness of the key diagnostic strategies and of the main
medical and surgical options available in the manage-
ment of IBD is recommended [EL3].
Inflammatory Bowel Disease (IBD) is an umbrella term
given to the life-long (‘chronic’) bowel diseases of which
Crohn's disease (CD) and ulcerative colitis (UC) are the
predominant forms. Although the causes of IBD are unknown,
it is recognised as an immune-mediated disease, possibly
precipitated by a mixture of genetic and environmental
factors which may include fastidious childhood hygiene,
smoking, or drugs (such as anti-inflammatories, the contra-
ceptive pill, or antibiotics).2–4 IBD commonly presents in
adolescence or young adulthood, and follows a currently
unpredictable relapsing and remitting course.
UC is confined to the rectum and colon. Originating
in the rectum (proctitis), it can extend proximally to the
sigmoid and descending colon (left-sided colitis), or the
entire colon (pan, or extensive colitis).5 The inflammation
is continuous and limited to the mucosa. Symptoms
include rectal bleeding and passage of mucus and faecal
urgency leading sometimes to incontinence. The location
and severity of disease activity determines the choice of
therapy.
CD affects the gastrointestinal (GI) tract anywhere be-
tween mouth and anus. It occurs most commonly in the ileo-
caecal region, followed by the colon. The inflammation is
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between areas of healthy mucosa. Symptoms vary according
to disease location and include abdominal pain, diarrhoea,
weight loss, anorexia and fever. Nausea and vomiting can
occur if strictures cause intestinal obstruction.6 Initially
starting as an inflammatory process, CD can progress to a
stenosing/stricturing or penetrating/fistulising pattern,
adding considerably to the burden of the disease. Fistulae,
which most commonly affect the perianal area, may also form
between bowel and skin (‘enterocutanous’), bowel and bladder
(‘enterovesical’), or rectum and vagina (‘rectovaginal’).
Management can be difficult, complex, and frequently requires
surgery.7
Medical treatments for IBD aim to induce and maintain
remission. Surgery will be necessary for approximately 30% of
UC patients and up to 70% of CD patients, at least once in
their lives.7,8 Extra-intestinal manifestations (EIMs) affecting
joints, skin, eyes and liver may occur.9 These can either run
in parallel with active disease or independently, even per-
sisting in the case of UC following colectomy. Common symp-
toms of active disease in both conditions include diarrhoea,
abdominal pain, anaemia and fatigue.
Patient history and physical examination are fundamental
in diagnosing IBD. Appropriate analysis or culture of diar-
rhoea (with or without blood) can exclude bowel infections
and infestations. Endoscopy with biopsy of the colon and
terminal ileum may establish and verify diagnosis. Blood
chemistry and haematology tests indicate the presence of
inflammation, anaemia and malabsorption. Computed to-
mography (CT) and magnetic resonance imaging (MRI) scans
enable evaluation of disease extent, activity and complica-
tions.6,10 Basic knowledge of diagnostic procedures enables all
nurses to support patients with their questions and preparation
for investigations.
The complex choice of single or combined drug therapy in
the medical treatment of IBD is influenced by the location
and severity of the disease, treatment availability and local
experience, and by individual patient circumstances such as
tolerance, side-effects, drug interactions, pregnancy and
personal preference. Detailed explanations of recommended
medical treatments are available in current ECCO consensus
documents.7,8 Local protocols and guidelines can also be
referred to.
Surgical interventions for UC include subtotal colectomy,
panproctocolectomy with a permanent ileostomy, or ileo-anal
pouch.8 Such surgery might be considered ‘curative’ for UC.
Surgery for CD may include small bowel resections, subtotal
colectomy and ileo-rectal anastomosis, or panproctocolec-
tomy and permanent ileostomy.7 Colonic resection is some-
times indicated for isolated disease, and surgery may be
necessary to treat fistulae and bowel strictures. Surgery can
improve quality of life in patients with CD and relieves pa-
tients with UC of unremitting inflammation, although EIM's can
remain.9 A consistent patient-reported fear around surgery is
the potential need for a stoma.11–14 However, stoma-forming
surgery may have significant benefits for health related
quality of life HRQoL.15
Timely therapeutic intervention is essential for disease
control. It is recommended that nurses with a basic knowl-
edge of IBD consult the Advanced IBD nurse or gastro-
enterologist where appropriate, according to local referral
procedures.2.2. Impact of IBD on patient's lives
N-ECCO Statement 2B
Nurses caring for patientswith IBD need an awareness
of the extra-physical impact of the illness, of patients'
key concerns, and the effect of IBD on Health Related
Quality of Life [EL4].
In addition to symptoms such as diarrhoea and fatigue, IBD
commonly causes patients psychological distress.16 There
may be concerns about the uncertain origins and course of
the disease, possibly requiring surgery and/or an ostomy bag,
achieving full life potential, loss of bowel control, being a
burden on others, producing unpleasant odours, and body
image.17,18 Hospital admission may compound worries about
personal achievement potential by causing unwelcome
enforced absence from work or studies.18
Despite being a major concern, IBD-related incontinence
is rarely reported or addressed, but incontinence remains
both a fear and a risk.19–21 Recent evidence suggests that up
to 74% of people with IBD experience faecal incontinence not
necessarily related to flare-up.22 During hospital admission,
difficulties with bowel control are more likely as relapse is
probable, and toilet facilities may be shared between several
patients, thus limiting availability. Urgency can be severe,
with some patients reporting less than 30 s between the call
to stool and the need to defaecate.23 Loss of bowel control
causes such concern that some patients with IBD always
ensure that they know the location of the nearest toilet.23,24
The nurse can provide empathetic support and may be in a
position to influence speedier/easier access to facilities.
Discreet assistance and maintenance of patient dignity in the
event of an incontinent episode is essential.
Health related quality of life (HRQoL) is influenced by IBD
in both remission and relapse, although perhaps more so
in the latter.25 Psychological wellbeing can be significantly
impaired regardless of disease type or status, possibly
attributable to sustained psychological distress.25–29 Psycho-
logical intervention or counselling support may be appropri-
ate for patients demonstrating higher levels of concern
although the benefits have not been fully demonstrated.30–33
Even in remission, background persistent disease-related
issues such as fatigue, extraintestinal manifestations and
sleep difficulties can also affect HRQoL.26,34,35
Individuals with IBD often find that their disease impacts
on many aspects of daily life, affecting relationships, school-
ing, socialising and work life. In a large European study un-
dertaken in collaboration with patient associations, 74% of
patients with IBD had taken time off work in the last year
owing to their IBD and 40% reported that their IBD had
prevented an intimate relationship.36 Furthermore in this
study, patients often felt that their HRQoL is not explored or
discussed properly with them during healthcare consulta-
tions, as 53% reported that they were unable, during a
consultation to discuss something important to them.
Contact with other people with similar health problems
may benefit many patients.37 Sharing experience with others
who ‘know’ what it is like to live with a condition 24 h a day,
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and psychological support.38 Nurses can provide contact
details for country-appropriate patient associations, support
groups, or patient-related charities. These fulfil an impor-
tant role in providing specific, accurate and empathetic
support for those dealing with a new diagnosis or with major
developments of established disease.
2.3. Patient advocacy
N-ECCO Statement 2C
Nursing involves advocacy for all patients and is of the
utmost importance to patients with IBD due to the com-
plex, uncertain and chronic nature of the condition. Ad-
vocacy for IBD patients includes identifying their needs
and ensuring appropriate access to specialist care [EL4].
An advocate promotes and supports the interests of
another.39 Traditionally rooted in law, advocacy is universally
considered a moral obligation in nursing practice, particularly
when the patient's ability to make decisions, and to defend or
protect themselves physically and emotionally, may be
impaired due to illness.40–42 There is no literature focussing
specifically on the nurse's role in advocating for patients
with IBD. However examples of advocacy in practice include
respecting patients' rights, representing, speaking up for the
patient's point of view, protecting dignity and privacy, and
defending them from interventions that might cause dis-
tress.43 Many of the interventions for IBD may cause distress,
but are necessary, and advocacy in such situations is focussed
on enabling the patient to access care which keeps distress to
a minimum. Advocacy requires the nurse to understand the
needs and preferences of the individual patients with IBD, and
to exercise moral and professional obligations to assist the
patient in meeting those needs. For non-specialist nurses, this
may include ensuring urgent and timely referral to Advanced
IBD nurses, gastroenterologists or stoma nurses with whom the
patient is already in contact, or assisting patients in voicing
their concerns to the team.
2.4. Communicating with the patient with IBD
N-ECCO Statement 2D
Communication is a two way process. Nurses need to
develop an empathetic and active listening role, and
be able to provide essential IBD-related information
and holistic support [EL4].
Communication is a vital aspect of the nursing role, with
verbal and non-verbal skills playing an important part in
meeting the needs of the patient. IBD impacts significantly on
patients' lives and presents themwithmany uncertainties. The
support, advice, compassion, caring and empathy they receive
from IBD nurses is considered highly important to their care.44
In any chronic illness where the individual will have
an ongoing relationship with health care professionals,communication is an important factor in building rapport and
trust.45 Establishing and maintaining an ongoing therapeu-
tic nurse–patient relationship is essential. It can be used to
encourage the patient to self-manage, to have an active,
rather than a passive role in their care and enable recognition
with respect for the patient's expertise about their own
illness.46–48 Nursing attributes most valued by patients are
listening, interpersonal skills, and empathy.44,49,50
Nurses involved at diagnosis of disease need to appreciate
that patients may struggle at various stages with the loss
of their healthy self.51 This can affect the way the newly-
diagnosed person with IBD gives, seeks, receives and pro-
cesses information.52 Worry, fear and their physical condi-
tion can affect their ability to process information, which
needs to be shared in a way that information cannot be
misinterpreted.52 Reliable printed information, leaflet, or
web-based materials are recommended to supplement
verbal information.53–56 In the absence of in-house patient
information leaflets, nurses can utilise those developed by
country specific IBD patients' associations.
Advanced IBD nurses may have the ability to provide
expert advice to patients about their IBD, but all nurses need
be empathetic, active listeners with sufficient knowledge to
give basic guidance on key areas of concern for patients.
These areas include diet (with appropriate reference to
specialist dietitians, who are members of the multidisci-
plinary IBD team), social problems, common symptoms and
complications of IBD, aetiology of IBD, medication and related
potential side effects, and surgical treatments.53 The nurse
can provide emotional support by enabling patients to express
their concerns. Non-clinical issues can sometimes be over-
looked in a routine medical encounter, and patients value the
opportunity to be listened to and ‘taken seriously.’ The nurse
may not, however, advise beyond their competency.37 With
awareness of available specialist resources such as Advanced
IBD nurses, stoma nurses, dietitians, or counselling services,
patient referral can be made where appropriate.
2.5. Fistulae
N-ECCO Statement 2E
In fistuliating IBD, nurses have a role in ensuring patient
comfort, protecting skin integrity and managing com-
plications. This can best be achieved by working in
collaboration with the wider multi-disciplinary team
(MDT) including stoma care therapists and tissue
viability teams [EL5].
Fistulating CD is defined as the presence of fistulae, often
arising in the perianal area as a communication between the
intestine and perianal skin, or the abdominal wall, or other
organs57 Five aspects have been identified as important for
planning the management of fistulae: i. identification or ex-
clusion of local sepsis; ii. assessment of nutritional status;
iii. location and anatomy; iv. evaluation of the originating intes-
tinal loop; v. determining organs affected by the fistula and
their contribution to systemic systems or impairment of HRQoL.
Management of fistulae remains one of the biggest chal-
lenges for all who care for patients with IBD. A combination of
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specialist intervention may be required in the management of
these disease complications. Development of enterocutaneous
fistulae are typically secondary to a local inflammatory process
often compounded by surgery and can result in significant
morbidity for patients, including fluid and electrolyte distur-
bance, abdominal pain and sepsis.58 Management of entero-
cutaneous fistulae is, therefore, considered to be a complex,
multi-disciplinary team (MDT) challenge often requiring
referral to a specialist centre.57 The role of the nurse in the
management of fistulae may include wound management,
medication administration, containment of sepsis, support and
liaison. The IBD nurse should not be expected to be an expert in
dressings or wound managers which may be required for the
management of specific types of fistula. However working in a
collaborative way with appropriate health care professionals
including stoma care therapists and tissue viability nurses, can
help to enhance patient care and comfort.
Surgical intervention to perianal fistulae may include
abscess drainage and seton insertion but can, in severe cases,
require diversion surgery or proctectomy. It is notable that one
postal questionnaire study addressed HRQoL in patients with
severe perianal disease and found that overall HRQoL tended to
be higher in patients who had undergone diversion surgery ±
proctectomy. However, it was also noted that the surgery itself
had a potential impact on certain activities such as sports,
swimming and sexual intimacy, highlighting the need for
careful discussion and consideration which takes into account
an individual's specific situation.59 Identification of the impact
of a fistula in terms of symptomology and effect on HRQoL can
help in planning appropriate intervention. In addition, identi-
fication of underlying disease activity and resolution of this
where possible can also help to improve outcomes.
Nurses need to provide education and signposting to
alternative sources of support where appropriate. Despite
this, there remains a limited amount of controlled evidence
to guide nursing management of fistulising disease as the
fistulae are often refractory to both medical and surgical
interventions and have a significant impact on HRQoL.49
Examples of support available to individuals with fistulae
include enabling careful, combined discussion between the
patient, surgeon and specialist gastroenterologist (a second
opinion might help and can be suggested without questioning
the care of the original clinician). In addition, referral to
patient support agencies, provision of information leaflets and
diagrams and, in specific situations, the consideration of
referral for more formalised counselling to help the patient
manage their symptoms and the impact on their daily living.602.6. Diet and nutritionN-ECCO Statement 2F
Nurses need an awareness of potential nutritional issues
in patients with IBD to ensure these are appropriately
identified and managed [EL 2]. Patients and carers may
require ongoing support and education from nurses
regarding nutrition and especially in specific situations
such as stricturing disease, or following surgery [EL 1].Patients often ask about links between dietary habits and
their IBD symptoms. However, epidemiological evidence to
support diet as a risk factor is lacking. Patients with IBD need
awareness of the importance of good nutrition in order to
maintain maximum health, particularly as they may lose
weight during episodes of active disease. It is important that
nurses, physicians and surgeons (as well as patients) rec-
ognise that dietary advice is generally best provided by a
dietitian with a special interest in IBD, who will often be
found in the multidisciplinary team of a centre specialising
in IBD. Generic or uninformed dietary advice may otherwise
generate confusion for patients. Some general principles are,
however, important for all members of the IBD team and for
the patient to understand.
There is no specific diet that works best for all patients. It
remains unclear whether dietary adjustments have a role
solely in symptom control, or whether complete remission
may be possible using dietary interventions in combination
with pharmacological agents.61 As no special diet has been
found to be effective in the treatment of adult IBD, patients
should be encouraged to follow a normal, healthy diet and
lifestyle as tolerated. In some patients, however, diet may
need to be tailored to meet individual needs based on symp-
toms and patient preferences.62 Specific dietary advice may
be required in the management of those with a concomitant
irritable bowel, strictures, following surgery and stoma
formation, short bowel syndrome, osteoporosis, anaemia,
or genuine food allergies.63
Access to appropriate dietary assessment and special-
ist advice is important to patients with IBD. During the course
of their illness some patients may experience general
malnutrition or specific deficiencies of individual nutrients.
A multitude of factors, including drug–nutrient interactions,
disease location, symptoms, and sometimes inappropriate
dietary restrictions can lead to nutritional problems im-
pacting on health, nutritional status and HRQoL. This is not
isolated to periods of active disease, since a wide range
of nutritional and functional deficiencies can be evident
after long periods of remission.64 The most common nu-
tritional deficiencies in IBD are macronutrients (calories,
protein and fat), vitamins (e.g.: B12 and D), folic acid, and
minerals (iron, calcium, magnesium, selenium, zinc) rele-
vant to anaemia and osteoporosis.65 The use of complemen-
tary or alternative medicines (CAM), nutritional supplements
(vitamins, mineral and trace element preparations), herbal
and homeopathic remedies, should always be discussed with
the treating healthcare team.
The impact of inadequate nutrition is more noticeable in
the growing child or adolescent. Dietary aspects should be
taken into particular account in the paediatric population,
since nutritional deficiencies can lead to a risk of growth
failure, delayed puberty, bone demineralisation or signifi-
cant psychosocial complications.57 For children with IBD,
nutrition is an integral part of management. The treatment
of choice for active paediatric CD is nutritional therapy in
which all of the patient's requirements for energy, protein
and other nutrients are met by a nutritionally complete
liquid diet. Exclusive enteral nutrition (EEN) is an effective
therapy for small and large bowel disease, inducing response
in 60–80% of cases.66 There are many benefits in considering
EEN as first line treatment in children with acute CD: it
proves an alternative to pharmacological treatment, helps
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tolerated than steroids and compliance is often better than
EEN in adults.57,67
Liquid feeds are, nevertheless, often found unpalat-
able and a finebore nasogastric (NG) tube can be used.
The child and family can be taught how to insert and
manage the tube, and how to follow the feeding regimen.
When an NG tube is required for school age children,
liaison with the local community nurse and/or school
nurse should occur to ensure the therapy does not disrupt
the child's education.682.7. Incontinence
N-ECCO Statement 2G
Nurses should appreciate the impact of incontinence on
HRQoL. Management of faecal incontinence should be
tailored to the needs of the individual. Formal specialist
referral for assessment and investigationmay be appro-
priate [EL2]. Specific interventions with IBD patients
can be beneficial such as pelvic floor exercises, evacu-
ation techniques, dietary advice or information on
continence products [EL1]. It is important to manage
patient expectations of care and outcomes realistically
and sensitively, taking lifestyle factors into account.
During hospital admission supportive interaction in-
cluding appropriate toilet access and ensuring privacy
and dignity is essential [EL 5].
Faecal incontinence (FI) can be a significant problem for
patients with IBD, affecting an individual's physical, psycho-
logical and social life. Fear of incontinence can leave IBD
patients housebound and unable to work.23,69
Often patients find it difficult to find the right words to
reveal or discuss their bowel symptoms openly. In order to
do so properly addressing the issue of FI, the stigma sur-
rounding it needs breaking down.70 Patients need to be
encouraged to ask for help if they require assistance and
nurses, simply by asking about symptoms, can encourage
patients to talk about continence issues. Nurses have a vital
role in helping patients to manage and improve the symp-
toms of FI. Strategies include information, along with
emotional and instrumental support. Nursing interventions
in the management of FI may also include pelvic floor muscle
exercises, perianal skin care, bowel retraining, medication
(such as anti-diarrhoeals), dietary management, behavioural
therapy (biofeedback), practical devices (including anal
plugs and pads), and electrical stimulation. These inter-
ventions have not yet been evaluated in an IBD cohort spe-
cifically, but it is possible such practical support, along with
optimisation of IBD treatments, will improve symptoms. It is
crucial for the IBD nurse to be aware that not all patients
will respond to the same nursing intervention. Therefore a
tailored care plan should reflect the needs of the individual
taking lifestyle factors into account.71 Specialist referral tolocal biofeedback or continence services, where appropri-
ate, is recommended.
2.8. Sexuality and IBD
N-ECCO Statement 2H
Issues relating to sexuality may cause anxiety and
concern for patients with IBD. Nurses identifying
problems regarding sexual function and sexuality need
to be able to support and refer as appropriate [EL5].
IBD commonly affects individuals during young adulthood
and an individual's sexuality and self confidence can be
affected significantly by a diagnosis of IBD. Sexual function-
ing is a marker for HRQoL. IBD can have a direct and indirect
impact on a person's body image, sexual functioning and
interpersonal relationships.72,73
Emotional aspects may include concerns about body
image, or worry about urgency or inappropriate leakage
during intercourse. The unpredictability of the disease and
fear of unexpected symptoms can lead to low self image or
self esteem.74 In order for sexual difficulties to be treated
they need to be identified.72 Although there is a paucity of
data in this area, the available literature identifies high
levels of sexual impairment reported amongst both male
and female patients with IBD with just over half reporting
that their IBD had impacted negatively on their rela-
tionship status.73 Surgery appears to increase this negative
impact in both males and females, particularly following
proctectomy.72 Libido was felt to be decreased in just over
half the respondents, equally affecting both patients with
CD or UC.
Busy workloads and changing personnel can make the
introduction of discussions regarding sexuality difficult to
initiate in clinical practice. However, the nature of the IBD
nurse/patient relationship can foster the confidence and
environment for these concerns to be raised. Facilitating
time and fostering long term relationships with patients is a
significant aspect of the Advanced IBD nurse role, and can
promote discussions and enquiry.
The role of the nurse varies from allowing enough time
during consultations for concerns to be raised, signposting
towards information and offering advice, to identifying when
there is a need for more structured support or specialist coun-
selling. Tactful prompting and open discussion will identify
the level of support needed.75 No formal tools for measuring
the impact of IBD on an individual's sexuality exist, but this
may be beneficial in promoting an individualised approach to
each situation.
Helping gay, lesbian, bisexual and transgender (GLBT)
patients solve problems associated with sexuality and
chronic illness requires nurses to understand and feel
comfortable discussing aspects of sexual practices of this
patient group.76 Nurses who feel under-informed can refer
to the extensive literature on GLBT experiences within
healthcare settings.77–79
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N-ECCO Statement 2I
Nurses may be well placed to identify, acknowledge
and provide treatment and support for patients with
IBD experiencing fatigue. Causes of fatigue may be
multifactorial and nurses, through discussion, may
help patients to manage [EL 5].The disease course of IBD is characterised by both intes-
tinal and extra-intestinal complaints and episodes of active
and quiescent disease. During a period of relapse patients
frequently complain of fatigue. Even in remission, more than
40% of IBD patients suffer from fatigue.80
Piper et al.'s definition, describing chronic fatigue as
‘unpleasant, unusual, abnormal or excessive whole body tired-
ness which is disproportionate to or unrelated to activity or
exertion and present for more than a month’, is widely used.81
Chronic fatigue, not dispelled easily by sleep or rest, can have
a profound negative impact on the person's quality of life.82
The aetiology of chronic fatigue can be multifactorial.
Physical assessment, biochemical and haematological test-
ing can provide possible explanations. Persistently low iron
stores, haemoglobin, vitamin D, or raised inflammatory
markers in the absence of bowel symptoms are examples of
reversible causes of fatigue. Adrenal insufficiency or hypo-
thyroidism are other potential causes. IBD nurses canmonitor
this in patients and provide advice on management. A 2004
review suggested that one third of patients with IBD suffer
from recurrent anaemia and that this might contribute sig-
nificantly to fatigue in this patient group. The authors
suggest that anaemia should be actively sought and treated,
using intravenous replacement if necessary in order to
minimise GI side effects, increase absorption and improve
quality of life.83 Conversely, a large Scandinavian study
found that fatigue was not associated with anaemia and/or
iron deficiency.34 This demonstrates the importance of an
holistic assessment of fatigue. Psychological factors and
HRQoL should also be explored. Psychiatric conditions can
coexist with physical illness, and literature suggests this
may be the case in IBD, with the prevalence of mood dis-
orders such as anxiety and/or depression in IBD possibly up to
three times greater than in the general population.84 Chronic
fatigue is associated with increased levels of disease-related
worries and concerns in IBD, which in turn are associated
with impaired HRQoL.35 Questionnaires, such as The Rating
Form of IBD Patient Concerns and The Fatigue Questionnaire,
can be used to quantify other aspects of living with chronic
illness, although no specific fatigue assessment for IBD cur-
rently exists.11,85
Fatigue is an important feature of IBD even when in
remission. Studies looking at HRQoL in IBD populations indi-
cate the prevalence of fatigue is higher than the general
population, but little research exists which defines the
severity of fatigue in this patient group, or identifies the
relevance of any possible contributory factors.34,86,87Once fatigue has been identified as an issue, it is im-
portant for nurses (and doctors) to monitor the individual to
determine any improvement or worsening of the symptom, as
this can fluctuate over time. The chronic nature of IBD makes
it important for health care professionalsmanaging individuals
to adopt a holistic approach to disease management.
If biochemical, haematological, or endocrine causes are
excluded, the nurse can work with the patient to identify
steps and coping mechanisms which may help to manage the
fatigue, with strategies such as: taking short naps during the
day; reducing night shifts; exercising regularly; getting a




Nurses may be well placed to identify, acknowledge
and provide treatment and support for patientswith IBD
experiencing pain. Causes of pain may be multifactorial
and not always linked to disease activity. Nurses,
through discussion and collaboration with MDT, may
help patients to manage this symptom [EL 2].
Abdominal pain is a common feature of IBD and often is the
first symptomatic presentation of newly-diagnosed or exacer-
bating disease.6,10,89 It can influence HRQoL and anxiety due to
its unpredictable nature and difficult management.27,90 The
mechanism of pain may be inflammatory such as stricturing
disease, fistulae, and fissures, or non-inflammatory such as
adhesions, fibrotic stricturing disease or co-existing functional
GI symptoms. Extra-intestinal factors including gall stones,
renal calculi, pancreatitis or joint and skin complications
may also cause symptoms of pain57,91 Complaints of pain
should trigger further investigations to uncover the cause.
These may include blood tests, imaging, endoscopy, or faecal
calprotectin.89,90 A sub-group of patients will continue to
experience pain despite there being no evidence of active
disease on investigation,90 and in this case it is essential for the
nurse to provide empathy and support the patient to manage
their pain. This may be a manifestation of anxiety and
depression or related to functional symptoms such as Irritable
Bowel Syndrome.84,89,92,93
The nurse, administrating medicaitons must ensure they
have a wide knowledge of pharmacological pain control
methods, and associated side effects and drug interac-
tions of the mainstay analgesics that may be used in IBD
patients.89The psychological burden of pain should be
recognised and addressed by clinicians. Therapeutic options
such as optimising IBD therapy may help. The use of opioids in
managing pain is complicated by side effects and depen-
dance from chronic use.90,94 The use of opioids has been
found to increase mortality, serious infection and cause
complications such as narcotic bowel syndrome, charac-
terised by abdominal pain of unexplained nature or inten-
sity that worsens with increased doses of opioids, and gut
dysmotility.95,96 Opioids should, therefore, be used with
caution. Tricyclic anti-depressants may be useful as an
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of pain is established, patients should be educated on
the cause of their pain and, in conjunction with the MDT
and pain management teams, empowered to recognise and
proactively manage their pain, for example by taking regular
analgesia.97 Cognitive and behavioural psychotherapy may
help patients to cope with pain and improve their quality of
life and functioning.90 A treatment algorithm for pain in IBD
can support decision making in clinical practice.90
3. Advanced IBD Nursing
3.1. Definition and requirements
In this document the term ‘Advanced IBD Nurse’ refers to
experienced nurses practicing at an advanced level caring
for patients with IBD (whether adult, adolescent or paedi-
atric). This level of practice is “evident of being beyond that
of first level registration” and would normally be attained
following a combination of extensive clinical practice,
professional development and formal education.98,99
N-ECCO Statement 3A
The Advanced IBD Nurse is an autonomous clinical
expert in IBD who is responsible for the assessment
and provision of evidence based care planning, and
treatment evaluation, and who provides practical
information, education and emotional support for
patients with IBD. They will practice within their own
professional competency and accountability, support-
ed by protocols or guidelines [EL 5].
Job titles which include the terms nurse specialist, clinical
nurse specialist (CNS), nurse practitioner, advanced nurse
practitioner, nurse endoscopist, or nurse consultant are
often used to describe the Advanced IBD Nurse. Although the
specifics of these roles will vary depending on national and
local needs, the international literature suggests commonal-
ities in the expected skills required to undertake these roles.
These include competencies in advanced clinical skills
(which may include undertaking procedures such as physical
assessment, endoscopy, or prescribing); nursing expertise;
the development of practice standards and provision of
evidence-based care; ability to analyse, critique and evalu-
ate evidence and outcomes; critical thinking; publishing
practice innovations or audits; the development of original
nursing research; leadership; education; and change man-
agement.98,100–103 Although autonomous practitioners, they
are likely to be supported by inter-departmental, national or
international protocols or guidelines.
Advanced IBD Nurses work as autonomous practitioners
in collaboration with their patients and MDT. They have
important roles in the assessment, nursing diagnosis, treat-
ment planning, evaluation, monitoring, surveillance, educa-
tion, health promotion, practical and emotional support for a
caseload of IBD patients within the scope of their own
professional practice and limitations.104 However, clinicalskills and expertise represent only one facet of the role of the
Advanced IBD Nurse.
N-ECCO Statement 3B
The Advanced IBD nursing role includes education,
research, service development and leadership. In
order to achieve these skills a broad clinical experience
and development of clinical competencies is ideally
supplemented by postgraduate education [EL 5].
Although it is acknowledged that the largest proportion of
the Advanced Nurses' time is spent in direct clinical practice,
it is considered that, in order to fulfil an Advanced Nurse's
role, they should be actively involved in the education,
research and service development.98,101,103–105 Individual
role requirements, such as the authority to prescribe, order,
or undertake investigations, or admit patients to hospital,
will be dependent on individual hospital or department
procedures, alongside national regulation and policy.
There is no consensus on the level of education such nurses
should attain. Requirements will vary between countries and
organisations, and may be governed by national professional
standards and regulatory requirements.99 It is generally
thought that CNS's should have a degree at minimum, while
those in advanced practice (for example those who are
assessing, diagnosing and prescribing treatment) should be
educated to Master's level, while consultant nurses or senior
university educators should have a Doctorate. Each hospital
is also likely to have its own expectations and objectives
for individual specialist nursing roles. The development of
explicit clinical competencies is often advocated as ameans to
achieve the necessary advanced skills.102,103,106
Research is a recommended core activity of the advanced
nurse role, but only 4% of time is dedicated to it, compared
to between 60 and 70% of time spent on direct clinical
care.98,103,105–107 Lack of dedicated time is often cited as
one barrier to integrating research into the role. Therefore
it is essential to ensure this component is acknowledged in
role descriptions and job plans. Nurses often feel they lack
the skills or confidence to conduct research.108 There are,
however, many ways to get involved in research and develop
knowledge and skills. These may include working with the
research team to identify potential recruits for currently-
running nursing or medical studies, identifying areas for
future research based on clinical experiences, or, indeed,
the development of original research questions and manag-
ing each step of the research process.109
A criticism of nursing as a profession and those in
advanced IBD nursing roles in particular, is that there is little
empirical evidence to support their value and contribution
to patient's outcomes.110,111 A systematic review of the
effectiveness of the Advanced IBD Nurse identified a need to
develop common competencies, to establish educational
requirements of nurses in these advanced roles and to
prospectively explore the impact of IBD nursing interven-
tions on patient outcomes.110 There should be no divide
between medical and nursing research, although nurses may
ask questions with a different, quality of life focus, such
N-ECCO Statement 3D
The Advanced IBD Nurse assesses understanding
and, informed by current evidence, provides educa-
tion to patients with IBD and their relatives based on
individual needs, preferences and coping ability. The
aim is to enable and empower the patient to live with
IBD [EL 3].
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employment and education, and financial implications of
disease, which are areas of concern for patients. These are
all topics which Advanced IBD nurses are well placed to
research and explore.
Leadership in health care is not confined to those in
management roles. Components of effective leadership
include practice leadership; role modelling; promoting pa-
tient safety; caseload management; evaluation of services
or interventions; facilitating improvements or innovation;
consultancy; being able to develop self and other; and
change management.98,112 Skills the Advanced IBD Nurse may
use in leadership include problem solving, critical thinking,
listening and engagement with the team or stakeholders.98
Leadership is pivotal to effecting change in clinical practice.
An evaluation of a nurse leadership programme showed
leadership skills improved team effectiveness and translated
into the provision of more patient-centred care.113 It has
been shown that the presence of an IBD nurse improves
services and that improvements in service quality are often
driven by the Advanced IBD Nurse.110,114,115
The Advanced IBD Nurse is frequently involved with policy,
protocol and guideline development, either independently
or with other team members. These can often form a frame-
work to support the clinical activities of the IBD nurse, such
as a protocol for IBD telephone or email Advice Lines (AL).
These types of documents may be required by organisations
for reasons of professional indemnity. However, it needs to
be acknowledged that Advanced IBD Nurses work beyond
protocolised care and have the freedom to use their clinical
acumen, whilst acknowledging professional limitations and
seeking advice where appropriate. Advanced Nurses should
be knowledgeable about the wider stakeholder or strategic
planning of healthcare resources that they work within (local,
regional or national level) in order to direct their own service
and provide appropriate patient-focused services based on
their needs.116
Networking and sharing of practice is an important aspect
of leadership. This may be within their organisation or in
national and international groups. N-ECCO is one such
example of an international nursing network which enables
practice development and best practice from a number of
countries to be shared. Some experienced Advanced IBD
Nurses will be very active in these networks, presenting best
practice and research findings.
3.2. Skills
N-ECCO Statement 3C
The Advanced IBD Nurse works as part of the MDT,
enhancing patient care and the patient experience,
providing efficient, holistic and accessible care [EL 5].
With growing numbers of patients with chronic illnesses,
healthcare systems are increasingly challenged to provide
necessary care and empower patients to participate in their
management. Advanced IBD Nurses play a key role in helpingto meet these challenges.117 A well established MDT has been
identified as important for continuity of patient care as well
as for professional colleagueship. Nurses are key workers
within the MDT and may have a coordinating role, with
comprehensive knowledge of the patient's condition, the
care and treatment plans and the continuity of these. The
coordinating role may include facilitating communication
within the MDT to reduce the risk of fragmented care.118
Skilled nurses who are competent in the management of
patients with IBD can influence how well these patients
accept and understand their illness.
The role of the Advanced IBD Nurse has been identified
as covering a wide range of skills and personal attributes,
making a real difference to patient care. The most
frequently described aspect of Advanced IBD Nurses’ role
is that they are ‘always there’, a constant and reliable
source of contact providing timely advice. As well as having
good listening skills, and trying to create time for patients
to discuss their problems, Advanced IBD nurses' personal
qualities and characteristics have been described as: kind,
caring, understanding, available, empathetic, sympathetic,
reassuring, calming, confidence, commitment and problem-
solving power.44,119
Communication skills are an essential part of nursing care
in general and for the Advanced Nurse in particular. Patient-
centred care involves talking to patients as individuals,
seeking to understand and respond to their needs and pref-
erences, and inviting them to participate and help make
decisions. Showing concern and empathy, treating patients
respectfully, proceeding without hurry and assuring confi-
dentiality, help to establish trust. Warmth and friendliness
helps nurses establish a rapport with patients and ease their
anxiety. Non-verbal communication−such as eye contact,
facial expressions, gesture, and touch− is as essential as
words to all of these behaviours.120 Additionally nurses need
advanced communications skills when dealing with patients
who are mainly using telephone contact.
Advanced nursing practice achieves a high level of credibil-
ity. This is strengthened by continuing self-evaluation, a
constant reference to patient care, an involvement in research
and a contribution to practice-based theory and critical re-
flection in practice. Nurses have a distinctive way of thinking
about their practice and a clear vision for the future of nursing.
Advanced IBD Nurses also need to be able to identify the gaps in
their own knowledge and skills; and access the wider resources
available to them to improve their skills in order to maintain
and develop a high quality of care.3.3. Patient education
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cation is an important consideration for patients and may
need a variety of forms (such as group, individual, or
include the involvement of relatives).121 Patient education
may need to be repeated and be supported by direct access
to the MDT or other sources (e.g.: phone, written informa-
tion, electronic means, and country-specific patient support
groups). A wide range of information about IBD is available on
the internet. The quality of this information varies greatly and
should only be used as supplemental information to more
individualised education.54,55 Studies on structured patient
education have, to some extent, shown an increase in the
participants level of knowledge, but no significant effect on
HRQoL.122–125
Since some patients choose not to participate in struc-
tured patient education, a broad range of alternatives has to
be available. Information may bemore successful in engaging
people if a tailored approach is used.126 Tailored education
targeting subgroups of patients with IBD could be appropriate
(e.g. gender specific, age groups, or behaviour of disease). A
2008 ECCO consensus on patient quality of care recommends
delivery of patient-centred information to meet patients'
needs, but does not specify how information should be
provided.111
The Advanced IBD Nurse in particular, possesses refined
assessment and communication skills and as a result plays
a key role in the MDT, focusing education on enhancing
IBD patient knowledge, adherence and empowerment. The
Advanced IBD Nurse has the ability to screen patients and
offer education and support, based on level of patient care
and stage of treatment plan, providing a constant contact
point for patients' needs.
Self-management programmes for patients with UC have
been introduced and evaluated. There is no clear evidence
that self-management either improves health or increases
wellbeing, with two main studies showing no difference
in the quality of life in self-management, despite earlier
access to medical treatment in the event of a relapse.127,128
Despite this, some groups continue to recommend that IBD
nurses facilitate self-management.129 Findings from a cluster-
randomised trial in the UK evaluating self-management versus
treatment as usual, found there may be reduced economic
cost for patients allocated to self-management compared
to usual treatment yet the health related quality of life
actually worsened in both the control and self-management
group.130
Education towards self-management complements tra-
ditional patient education in supporting patients to live the
best possible quality of life with their chronic condition. As
well as teaching problem-solving skills, a central concept
in self-management is self-efficacy—confidence to carry
out behaviour necessary to reach a desired goal.131 The
Advanced Nurse's role is important in working towards
increasing an individual's self-confidence in their ability to
manage their disease, thus helping them deal with feelings
of helplessness and embarrassment that they experience.
Self-help groups can provide a range of services to help
the patient. These services include initial support at the
time of diagnosis, continued support, including family help,
provision of information, social activities and support for
research into the treatment and prevention of the disease in
question.3.4. Information giving
N-ECCO Statement 3E
Nurses at an advanced level may provide expert
knowledge and understanding of the evidence for
standard treatments, as well as the role of Comple-
mentary and Alternative Medicine (CAM) relevant
guidelines and Health Promotion issues, supported
with written information where available [EL5].
Patients want to be sure that what they have read about
IBD is reliable, regardless of the source. The nurse at an
advanced level should be able to identify, analyse and
classify relevant literature. The Advanced IBD Nurse is well
placed to be actively involved in health promotion such as
advocating smoking cessation or participation in surveil-
lance programmes. IBD teams are encouraged to support
patient organisations' educational and open forum sessions,
allowing patients to become more involved in shaping local
services.132 Introducing patients to their local or national
patient organisations is fundamental as there is evidence
that support groups improve patients' knowledge of IBD,
and increased disease knowledge has been associated
with improved coping and adherence to treatment.125,133 A
survey of 74 recently-diagnosed patients investigated their
need for information. After two months, the main source of
information was the doctor and the internet, but two thirds
of the patients indicated that they preferred information
from a nurse specialist.53
Nurses at an advanced level may also use a risk analysis
approach in discussion with patients, perhaps to explain the
risk of smoking, but also to weight up the risks and benefits of
treatment or a specific therapy, including CAMs or other
unproven therapies.8,57,134 Adherence to treatment and any
combination of treatment with CAM should also be discussed.
For patients with special needs (medical, cultural, mental,
social), the Advanced IBD Nurse plays a key role in linking in
with appropriate services in the MDT.135
3.5. Pregnancy and fertility
N-ECCO Statement 3F
The Advanced IBD Nurse needs to provide support and
information for patients and partners prior to concep-
tion, throughout pregnancy and following childbirth.
Liaison with other health care professionals may be
necessary [EL 5] Discussions regarding pregnancy
should be initiated, wherever possible, prior to concep-
tion [EL 5].
Pregnancy and fertility can be emotive and sensitive. For
IBD management it can generate complexities, and pa-
tients often express concerns about issues such as potential
hereditability, using medications during pregnancy and
breastfeeding, or best mode of delivery. ECCO has produced
consensus on reproduction in IBD and guidance to support
clinicians in the management of patients during pregnancy
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practice.91,136–139 These documents provide an evidence-base
to underpin medical and advanced nursing practice in the
clinical management of people with IBD. All IBD nurses should
be aware of these documents in order to support patient
discussion and to help provide education and promote health.
Research suggests a significant deficit in pregnancy-
related knowledge in women with IBD.140 The position of
the Advanced IBD Nurse within the team and the relationship
they form with patients can often result in them being the
health care professional with whom such matters are raised;
they may provide a useful role in the support and education
of male and female patients at the stages of family planning
including contraception, during pregnancy, delivery, and
post-natally, along with alleviating concerns about other
issues such as hereditability, delivery or breast-feeding.
These issues are the subject of the ECCO Consensus on
Reproduction and IBD.138
Women and men are often concerned about the potential
effects of medications to foetal health. Nurses, with the
appropriate knowledge, can support people to make appro-
priate choices based on the risk/benefit profile of their
individual situation, in conjunction with their treating
consultant.136,137,141 Other resources such as the Food and
Drug Agency (FDA) and local medicine information services
can be further inform discussion, although it should be noted
that the FDA recommendations on the safety of some drugs
for patients with IBD in pregnancy differ substantially to
expert opinion on both sides of the Atlantic.138,142
In general it is advised that patients are encouraged to
have early discussion about pregnancy plans with their
treating team in order that treatments can be assessed and
optimised if necessary to maximise pre-natal health.138 The
Advanced IBD Nurse can work with the patient throughout
her pregnancy to minimise risk of relapse and ensure review
takes place at timely intervals. In more complex patients,
such as those with perianal disease, and ileoanal pouch or
those at high risk of future colectomy, it is desirable for the
gastroenterologists and the obstetric team to work together
to ensure the most appropriate decisions are made regarding
delivery. Often nurses facilitate this type of team working,
advocating for the patient.142
3.6. Transition
N-ECCO Statement 3G
Special consideration needs to be given to the care
needs of adolescent patients with IBD. Adolescence is
a challenging time with individuals undergoing life
changes in addition to their clinical needs. Wherever
possible, an Advanced IBD Nurse should be involved in
a formal process for the transition of patients from
paediatric to adult services, in keeping with agreed
local transition models, addressing the physical, social,
educational and psychological needs of the young
person [EL 3].
All children with a chronic disease will need to be
transferred to adult services at some point, with the age
depending on local policy. Preparing young adults for thisprocess is very important as they need to develop a sense of
independence and responsibility. Transition should be seen
as an ongoing process rather than a one-off event.143
The aim of successful transition is to provide the best
care possible that will allow adolescents with IBD to become as
functional, healthy and well in adulthood as their disease
allows. There are two conceptual elements: the child taking
responsibility for his/her disease management from parents,
and the adult gastroenterologist taking responsibility of the
adolescent from the paediatric gastroenterology team.144
Advanced IBD nurses are often central to the smooth and
successful management of children with IBD and their parents,
during the transition process.145 Preparation, along with good
communication, is crucial if young people are to engage and
participate in the process of transition.146 Transition needs to
be tailored to an adolescents individual needs, e.g. the
paediatric gastroenterologist should continue to follow those
patients with delayed puberty who still have some potential to
grow.147,148 Young people need well-developed social, inter-
personal and emotional skills to successfully enter theworld of
adult health care. It is a difficult period for a young person
undergoing physical and emotional change to take on this role
when they are handed over to an adult centre. It may also be
difficult for parents, who may be unsure of their role and
responsibilities in this new setting.149
A stepwise programme for care transition, aimed at
coaching the adolescent patient into self-management will
benefit patients, parents, and the ‘adult gastroenterologist’
who will take over the care from the paediatric gastroenter-
ologist.150 There are a number of tools and models which
support adolescent transition and guidelines for transition of
patients with IBD have been published in the US and in the
UK.144–150 The model chosen for transfer will depend on local
resources. Whichever model is chosen, continued audit is
imperative to ensure outcomes are improved and maintained.
3.7. Biological therapies
N-ECCO Statement 3H
The Advanced IBD Nurse involved in the management
and delivery of biological therapy is in a position to
ensure that appropriate screening and identification of
any contraindications to therapy are identified and
recorded. Adhering to country-specific guidelines and
local protocols enhances safe administration [EL 5].
Ideally the choice of biological agent should be guided
by patient preference, but in reality this may be influenced
by a number of factors including physician experience, local
funding arrangements, previous response to therapies, and
disease phenotype.7 Studies have shown that patient's
under-estimate the risk of lymphoma with biological thera-
pies and have high expectations of duration and extent of
remission. It is therefore vital that education regarding
these aspects of care is addressed when trying to managing
patient expectations.151,152
The Advanced IBD Nurse is best placed to facilitate
such education and ensure information is conveyed in an
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the Paling Palette are useful when discussing adverse events
as they present evidence-based data in a pictorial form,
comparing risk to situations that patients can easily relate to,
and enhancing their understanding.153 Biological therapies
increase the risk of opportunistic infection so pre-treatment
screening is of utmost importance. Evidence based guide-
lines exist and should be incorporated into clinical practice
prior to initiating biological therapies.154 All patients should
be carefully screened to ensure that specific drug inclusion/
exclusion criteria have been reviewed prior to administering
biologics. Screening should involve a combination of blood
monitoring, radiologic and risk assessment including immu-
nisation history and relevant co-morbidities e.g. cardiac
history. In the situation of home administration, patients
should be counselled about the risks of opportunistic in-
fections. It is important that patients are made aware of
their responsibilities to report infections and attend for
monitoring. Screening results may require onward referral
by the nurse to other specialities such as respiratory or
infectious diseases. Any nurse involved in the administra-
tion of biological therapies should be skilled and competent
in the administration and management of infusions and
educating patients how to self-administer.155 When teaching
patients to self-administer biological treatment, a training
plan and assessment of the patient's ability and competence
are essential and should be well documented. Nurses need
to be aware of treatment side effects, how to manage infu-
sion reactions, and must support their practice with evidence-
based protocols.132,156 Checklists are a good safety measure
for documenting that key pre-treatment steps have been
addressed. The Advanced IBD Nurse should use their exper-
tise to influence IBD care beyond direct patient contact, for
example, to facilitate teaching general ward nurses to
administer biological therapies or developing link nursing
roles.157
Assessment of patients' clinical response to biological
therapies, along with monitoring of side effects, potential
complications and biochemical response, can be undertaken
by the Advanced IBD Nurse following agreed protocols either
at the time of administration or at follow up.158 Some
centres undertake this in the context of a Virtual Biologics
Clinic which allow multidisciplinary review and management
of patients on biologics.159
3.8. The nursing assessment
N-ECCO Statement 3I
The advanced IBD nursing assessment is both wide
ranging and able to focus on specific areas of concern.
The nurse may use biomarkers, imaging and physical
assessment including endoscopy providing appropri-
ate training has been undertaken. The Advanced IBD
Nurse needs to be aware of existing assessment tools
that may be useful aids in the management of patients
with IBD and their related health problems [EL 5].
Most nurses will have been trained in the use of the
nursing process which gives a framework for the care of apatient.160 In order to make a plan of care for any patient
in any situation whether face to face in clinic, over the
telephone or via email a thorough, competent and relevant
assessment is vital.105,161–163 The purpose of the assess-
ment is to determine and record care needs and current
health status which is to be used as a basis for planning, and
determining the response to treatment and/or interventions.
Nurses trained using a bio-psycho-social approach to assess-
ment may divide their assessment into these categories.
Other methods may be utilised but any approach needs to
include the following: disease and health history (including
co-morbidities, medication and any use of CAM, efficacy of
treatment and drug side effects); current disease activity
including extra-intestinal manifestations; dietary history;
HRQoL; coping strategies and health behaviours e.g. smoking,
drug adherence; psychological well-being and social support,
and disease related knowledge.
At the first meeting with a patient it is helpful and nec-
essary to gather a comprehensive ‘IBD history’. This may
include age at diagnosis, extent and duration of disease, any
surgical procedures, current and past medication, any drug
side effects or intolerances, dietary triggers or intolerances.
It is also important to gauge the patient's understanding
of IBD, its management and the care they are receiving. In
taking the time to carry out this holistic assessment, the
Advanced IBD Nurse is often best placed to identify what
have been termed ‘un-promoted issues in IBD’ including the
presence of functional GI disorders, problems with sexuality,
fertility, drug monitoring and compliance, incontinence,
fatigue and anaemia.164
It is helpful to use a validated disease activity scoring
system to aid the consistent assessment of disease severity
by which treatment decisions may be made. It may also
enable improvement or deterioration in the patient's
condition to be measured objectively, and help with audit
and research. Several validated clinical scoring systems can
be used in clinical practice, such as the Harvey Bradshaw
Index for CD, or Simple Clinical Colitis Activity Index for
UC.165–167 Furthermore, the Advanced IBD Nurse may use
other assessment methods such as abdominal examination,
endoscopy, interpretation of blood results and other bio-
markers, interpretation of radiology, histology and other
imaging tests, all according to training, skills and local
protocol.168
During assessment, the presence of any fever, nausea,
vomiting, weight loss, fatigue or other signs indicative of
active disease should be noted. In assessing a patient's
psychological well-being and HRQoL it may occasionally be
helpful to use an objective measure such as the Inflamma-
tory Bowel Disease Questionnaire or the Hospital Anxiety and
Depression scale.169,170 Other scoring tools may be appro-
priate in certain situations, such as pain or fatigue scores. In
all cases, where possible, there has to be consistency within
local practice. An assessment proforma can be developed by
the Advanced IBD Nurse for use during outpatient consulta-
tions or when conducting telephone assessments.162 Such
proformas help ensure a consistent approach to assessment
and can be used by any level of nurse.
As IBD impacts upon the patients' social function, the
Advanced IBD Nurse can assess the patients' existing re-
sources both within the family and wider social structure.
Despite reporting similar levels of stress that are unrelated
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higher disability rate and more days of sick leave com-
pared to the general population, but have enhanced social
support.171–173 The Advanced IBD Nurse needs to have some
knowledge regarding national law for work environment for
citizens' having a chronic disease, and should be able to refer
the patient to additional support, if needed.3.9. The Advanced IBD Nurse role in the follow up of
IBD patients
Advanced IBD Nurses are involved in the care of IBD patients
over a long period of time as the natural outcome of being a
consistent team member and working with clients who have
a lifelong condition. This continuity has been suggested as
one of the advantages, over other staff groups, such as
specialist registrars for their involvement in follow-up.174,175
Since the role of the Advanced IBD nurse is pivotal to the
provision of expert nursing care163 nurses have a role in the
follow-up of patients during relapse as well as in remission,
providing a link between the family doctor and hospital care,
providing rapid access in the event of a flare up.176,177
N-ECCO Statement 3J
The Advanced IBD Nurse who reviews patients inde-
pendently of medical colleagues has an added respon-
sibility to raise any issues of concern that fall beyond
their scope of practice with appropriate colleagues,
and need to be aware when it is necessary to refer
patients on [EL 5].However autonomous in their practice, the Advanced IBD
Nurse will undoubtedly identify problems and issues which
they are not knowledgeable or competent to treat and
manage. In order to maintain accountability and deliver a
safe service, appropriate medical support should be avail-
able to consult with and provide support in the event of new
findings or complex cases. The Advanced IBD Nurse will also
have an understanding of the potential EIM's of IBD such as
joint, skin or eye problems, be able to recognise symptoms
resulting from these, and know when to refer on to relevant
associated specialists.178
The Advanced IBD Nurse may also play a key role in iden-
tifying actual or potential psychological problems.16,179
Patients with IBD have a higher rate of anxiety and de-
pression compared with the general population.30,180 Pa-
tients who seek psychological support are more likely to be
females with concerns regarding: burden of disease, pain,
suffering, financial problems and sexual performance.181
Newly-diagnosed patients, or those with disturbing symp-
toms or having undergone surgery may need special atten-
tion.182 The nurse may be able to identify IBD patients with
increased risk of having, or developing, anxiety and depres-
sion, and also needs to know what psychological support is
available locally and how to access it.3.10. The Advanced IBD Nurse role in managing
Advice Lines
N-ECCO Statement 3K
Advice Lines are considered a key element of an
advanced IBD nursing role and may improve clinical
and service outcomes [EL4]. This type of contact is
suitable for providing many aspects of care, including
information and support, and the assessment, inves-
tigation and treatment of the unwell patient [EL5].
The most frequently-cited benefit of an IBD nursing service
from the patient perspective is an access point for prompt
resolution of relapse.44,183,184 It has also been described as an
element of “best practice” in an observational study involving
audit and questionnaires in eight European countries and a
‘lifeline’ in one qualitative study of patient follow-up care
needs.175,185
As well as the treatment plan, there are many other facets
of life for the patient and challenges continue through
different stages of, as well as changes in, the condition. Issues
around schooling and employment, smoking, diet, pain, fer-
tility and pregnancy, travel, sexual and other relationships,
medical compliance, stigma, transition from childhood to
adulthood, fatigue and more may be addressed via a tele-
phone or email Advice Line (AL).141,186–189 Advanced IBD
nurses are in a good position to have access to appropriate
information and to be able to direct a patient appropriately.
ALs, as part of an IBD nursing service, can reduce visits to
outpatients and length of inpatient stay.188 AL services can
negate the need for some face to face reviews, but may
also be perceived as a means of keeping patients away
from outpatient clinics.190 One aspect of the AL is to provide
prompt access to clinics when clinically appropriate, as
occurs in other specialist services such as diabetes nurs-
ing.191 It is important, therefore that an IBD service not only
manage the AL but also be able to provide other aspects of
support surrounding the service such as adequate consul-
tant support and urgent clinic slots, in order to function
effectively.
Some studies have suggested that AL increased remission
rates. However, study reliability may be questioned and it
cannot be directly inferred that the AL was the causative
factor in the improvement in care.174,184 Still, it is acknowl-
edged that having an AL service supports an efficient and safe
IBD service.192–195
It is essential that advanced communication skills are
utilised when using remote assessment especially as non-
verbal cues cannot be used.196,197 For example, the UK
General Medical Council guidelines for prescribing over the
phone or via other non face-to-face methods outline some
helpful parameters to ensure safety when doing such as-
sessments.198 Emphasis is placed upon appropriate compe-
tency and knowledge of the practitioner, establishing a
current history in context of the past, the importance of
documentation, and passing on the consultation appropri-
ately.198,199 Different levels of autonomy will accompany
different experience, competency and qualification. Services
N-ECCO Statement 4A
The Advanced IBD Nurse provides a pivotal and
important role in the care of the IBD patient, which
benefits the patient, the MDT, and the healthcare
provider [EL 5].
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training, protocols and legal confines.
It should also be noted that the nurses managing an AL
should be sufficiently experienced and competent to identify
the patient's needs and redirect as appropriate. Enquiries or
concerns may not all be IBD-related. Protocols should be
developed so that nursing and medical staff have agreed
expectations of an AL service.185 Local protocols will reflect
local practicalities and legalities. Protocols should outline
the aim, lines of responsibility, and the remit agreed for
those involved in running an AL.118,200
3.11. The IBD nurse role in the planned review and
care of stable patients
N-ECCO Statement 3L
The Advanced IBD Nurse can conduct patient reviews
face to face, via telephone consultation or by elec-
tronic means [EL4]. If carrying out non face-to-face
assessments the Advanced IBD Nurse must be aware
of the limitations of this type of contact and use skilled
judgement in knowing when further review may be
needed. Regular review enables the IBD nurse to
monitor the patient, their treatments, and arrange
appropriate investigation as required [EL 5].
Definitions of ‘remission’, such as detailed in the ECCO
Consensus guidelines for UC and CD, apply to a person's state
at any given period of time.6–8,10 and this is part, but not
the entirety, of the definition of the ‘stable’ patient
referred to here. Individual services will need to clarify
what they define as ‘stable’ by considering aspects such as
current medication and past medical history alongside the
type of follow-up they are able to provide. It is important to
recognise that there are many potential settings in which a
nurse may review patients who are considered stable,
whether in remission or on stable treatment which is being
adequately monitored such as face-to-face clinic in the out-
patient setting, over the telephone, as well as virtual clinics
(see Section 3.7).
The routine review of stable patients has been cited as
part of the incentive to setting up IBD nursing services. In
some studies it is suggested as an alternative to address
the limitations of time and space in outpatient consulta-
tions with medical staff and resulting in the reduction in
the number of outpatient clinic appointments needed.174,176
As with AL assessment by telephone, it is advised that the
same systematic approach to assessment is followed. It
should also be added that yearly follow up clinics are a
valuable opportunity for assessing the impact of the disease
on HRQoL which may alter over time.36,195
The aim of long term follow-up in IBD is to assess the safety
and efficacy of IBD therapy, thorough assessment of disease
activity, monitoring of adverse events and side effects. This
also encompasses reviewing laboratory tests, arranging
screening examinations such as surveillance endoscopy for
colorectal cancer, assessment of patients' HRQoL addressing
resources to improvement compliance and coping, and assess-
ment of patients' and families' needs.With regard to medication review, it is important to en-
sure that treatment remains appropriate according to cur-
rent guidelines. Follow-up is also important for assessing and
encouraging good treatment compliance and appropriate
monitoring.174,176
It must be recognised that the role of the Advanced
IBD Nurse should not be divorced from the MDT. The level of
availability of, as well as expertise from, medical profes-
sionals should be considered when setting up follow-up
clinics, as the team support and accessibility is imperative
for the safe running of such services. The Advanced IBD Nurse
may have an autonomous role but this ideally is as part of the
wider multidisciplinary team.
N-ECCO statement 3M
The Advanced IBD Nurse has a responsibility to
document clearly and communicate where relevant
beyond the direct MDT, adhering to country specific
policy. Regular audit and survey to review process
and ensure quality is recommended [EL5].
It is important to ensure that accurate and comprehensive
documentation is recorded in a manner and place that are
accessible to all relevant members of the MDT.185,201 It
should be recognised that a growing number of centres are
developing email or web-based consultation tools. As use of
remote methods of reviewing patients are developed, the
basic principles of communication and support need to be
maintained. It may also be appropriate to restrict usage of
these remote consultation methods to stable patients until
the evidence base for safety of practice expands. It is strongly
recommended that clinics should be based on a well-
maintained database with good integration of IT systems and
with both clerical and Advanced IBD Nurse support.202
As with ALs, protocols should be developed so that
nursing and medical colleagues ad patients have agreed
expectations of this nurse-led service.185 Local protocols will
ensure that the practicalities and legalities of local practice
are taken into account. Protocols should outline the aim,
lines of responsibility, and the remit agreed for those
involved in running the service200,201 Audit of the service
must be undertaken to assess usage and ensure quality of
care and patient experience.
4. The perspectives of IBD Nursing
4.1. The benefit of an Advanced IBD NursePatients with IBD are positive about, and appreciate the
role of, the Advanced IBD nurse.44 Benefits identified for
758 M. O'Connor et al.patients include: increased access via telephone ALs and
nurse-led clinics, especially at times of disease exacerba-
tion; the ability of specialist nurses to appropriately assess,
investigate, modify treatment, monitor and review IBD pa-
tients via treatment guidelines; provision of emotional and
physical support; reduction in outpatient attendances and
waiting times. Furthermore, the Advanced IBD Nurse can
play an important role as case manager in the IBD team,
providing an accessible point of contact for the whole team
and their collaborating specialists.
There is evidence that IBD Nurses are carrying out
significantly complex management of patients with IBD and
this in turn releases resources and physician time to manage
more complex patients.116 Such involvement is recognised as
an important contributor and supplement to the conven-
tional follow-up of these patients.181 The debate surround-
ing the future role of various health-care professionals in
the management of patients with long term conditions,
including IBD, has, in part, been prompted by the increasing
incidence of these conditions, with subsequent demand on
the healthcare system, as well as focus on health promotion
and prevention. Despite the recognition that Advanced IBD
Nurses are of clinical importance for the management of
patients, the effect of such involvement on patient reported
outcomes (PROs) remains scarcely studied. However, nurse-
led follow-up has been shown to result in shorter time span
from start of relapse to start of appropriate treatment.176
There is emerging evidence from the UK IBD National Audit
which demonstrate that IBD nurses, as part of a multidis-
ciplinary team, help reduce hospital admissions, increase
the proportion of people with IBD to self-manage and are
pivotal in offering greater patient choice of care.203
Advanced IBD Nurses reduce direct healthcare costs when
enabled to be pro-active in coordinating care within and
outside of the hospital setting, but increased staff numbers
are required to sustain these cost-effective benefits.204
Education is a key role of an advanced IBD nurse, however
this is not confined to patient education. A significant
contribution can be made to developing the knowledge and
skills of the fundamental IBD nurse in clinical areas such as
out-patient departments, endoscopy units and hospital wards.
The views of patients with IBD are increasingly being
heard via national patient organisations, with support at a
European level from the European Federation of Crohn's and
Colitis Associations. Advanced IBD Nurses have, through
national and international bodies (such as the Royal College
of Nursing (UK) and N-ECCO) represented these views,
influencing practice, service delivery and have been drivers
for change. These N-ECCO consensus statements are one
such example of nurses' increasing sphere of influence.
4.2. The need for high quality research on IBD
nursing in EuropeN-ECCO Statement 4B
Further research is needed to assess the impact of IBD
specialist nursing interventions. To achieve this, the
Advanced IBDNurse needs to participate in and conduct
research activities appropriate to their role [EL 5].Advanced IBD nursing interventions might provide benefit
for IBD patients. However, a Cochrane review published in
2009 reported only one which suggested this. This particular
study was assessed as low quality and the results of this
study therefore, should be interpreted with caution.110
There is a vital need for higher quality trials of the
advanced IBD nursing interventions in order to assess their
impact on the care and management of IBD patients. More
robust studies are needed in IBD nursing, and the current
challenge for all IBD nurses is to produce the evidence which
will demonstrate the relevance of their role in caring for
patients with IBD. Collaboration with clinical academics
and established IBD researchers can offer guidance and support
and help overcome the initial difficulties in conducting
empirical research. The next step would be to demonstrate
that IBD nurses help improve desired health outcomes in
patients. These two steps will require the design and imple-
mentation of research projects aimed at covering the gaps in
knowledge, especially the association between nursing inter-
ventions and patient outcomes.205 Collaboration through
N-ECCO may be an appropriate means of conducting this
research on a European wide scale to provide the best results.5. Conclusion
The N-ECCO Consensus statements aim to provide practical
value at a local, national and international level in the
development of nursing care for patients with IBD.
These statements are intended to be used as a means of
informing nurses, improving their knowledge and understand-
ing and so raise the standard of care for patients with IBD.
The European nursing collaboration achieved with the
N-ECCO Consensus statements provides a platform for future
partnerships of nursing to perform research and other de-
velopments, which will in turn, raise the standard of care for
patients with IBD across Europe.Conflict of Interest Statement
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